mutLBSgeneDB |
Gene summary for ZNF473 |
Gene summary |
Basic gene Info. | Gene symbol | ZNF473 |
Gene name | zinc finger protein 473 | |
Synonyms | HZFP100|ZN473 | |
Cytomap | UCSC genome browser: 19q13.33 | |
Type of gene | protein-coding | |
RefGenes | NM_001006656.1, NM_015428.1, | |
Description | zfp-100zinc finger protein 100 homologzinc finger protein ZFP100 | |
Modification date | 20141207 | |
dbXrefs | HGNC : HGNC | |
Ensembl : ENSG00000142528 | ||
HPRD : 11721 | ||
Vega : OTTHUMG00000183054 | ||
Protein | UniProt: Q8WTR7 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ZNF473 | |
BioGPS: 25888 | ||
Pathway | NCI Pathway Interaction Database: ZNF473 | |
KEGG: ZNF473 | ||
REACTOME: ZNF473 | ||
Pathway Commons: ZNF473 | ||
Context | iHOP: ZNF473 | |
ligand binding site mutation search in PubMed: ZNF473 | ||
UCL Cancer Institute: ZNF473 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0006398 | histone mRNA 3'-end processing | 16714279 |
Top |
Ligand binding site mutations for ZNF473 |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | H580 | Q579E | BLCA | 1 | C349 | Y347H | COAD | 1 | H609 | R611I | COAD | 1 | H836 | H836N | COAD | 1 | C651 | E650K | COAD | 1 | H286 | H286D | HNSC | 1 | H286 | T287S | LUSC | 1 | H836,H832 | R834G | LUSC | 1 | C651 | G652R | STAD | 1 | H609 | R611K | STAD | 1 | H609 | R611K | UCEC | 1 | C679 | D680N | UCEC | 1 | H668 | A669T | UCEC | 1 | H453,H449 | R451Q | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for ZNF473 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | H836 | R834G | -1.5921508 | H832 | R834G | -1.5921508 | H609 | R611K | -1.2266053 | H449 | R451Q | -1.1811866 | H453 | R451Q | -1.1811866 | H286 | H286D | -1.0702882 | C349 | Y347H | -1.0700334 | C651 | E650K | -1.0312796 | C679 | D680N | -0.89965127 | H609 | R611I | -0.77552983 | H836 | H836N | -0.70151879 | C651 | G652R | -0.62843072 | H580 | Q579E | -0.58897354 | H286 | T287S | -0.5426255 | H668 | A669T | -0.53201234 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for ZNF473 from PDB |
Top |
Differential gene expression and gene-gene network for ZNF473 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for ZNF473 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for ZNF473 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of ZNF473 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of ZNF473 |
Multiple alignments for Q8WTR7 in multiple species |
LBS | AA sequence | # species | Species |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |